Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01810016 |
Title | NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Ludwig Institute for Cancer Research |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mount Sinai Medical Center | New York | New York | 10029 | United States | Details | |
Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
University of Pittsburgh Cancer Center | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
University of Virginia Cancer Center | Charlottesville | Virginia | 22908 | United States | Details | |
Austin Health, Ludwig Oncology Unit | Melbourne | Victoria | Australia | Details |